About Wysa
Wysa is a global leader in AI-driven mental health support, offering a platform that integrates conversational AI with human coaching to provide accessible and personalized care. For physicians, Wysa’s platform can serve as a valuable tool for extending mental health support beyond the clinic, complementing existing care without increasing clinical workload. The AI chatbot leverages evidence-based techniques such as Cognitive Behavioral Therapy (CBT), Dialectical Behavior Therapy (DBT), mindfulness exercises, and motivational interviewing to guide users through self-help tools and structured conversations.
The platform is designed to support a wide range of mental health concerns, including stress management, anxiety, depression, sleep improvement, and chronic pain. Wysa has received FDA Breakthrough Device Designation for its use in managing chronic musculoskeletal pain and related depression and anxiety, and its efficacy is backed by peer-reviewed research and clinical trials. It also includes built-in safety features to detect signs of distress, such as self-harm or suicidal thoughts, and can escalate to human therapists or local crisis helplines when appropriate. Wysa offers solutions for individuals, employers, insurers, and healthcare providers, with a focus on anonymity and security for users.
Focus Areas
Business Intelligence
| Key Investors | Kae Capital, pi Ventures, HealthQuad, W Health Ventures, Google Assistant Investment Program, British International Investment (BII), Wellcome Trust, Zurich Innovation Championship, The NHS Innovation Accelerator, 100x Impact, Villgro |
| Partnerships | Swiss Re, RxCap, Imperial College London, Blackcountryhealthcare, Aetna International, Accenture Global, L'Oreal |
| Acquisitions | Kins, April Health |
| Technology | AI-powered conversational platform, cloud-based infrastructure, evidence-based cognitive-behavioral techniques (CBT), dialectical behavior therapy (DBT), natural language processing |
| FDA Clearances | 1 (Breakthrough Device Designation for chronic musculoskeletal pain, depression, and anxiety) cleared products (estimated) |
What Physicians Need to Know
For physicians, Wysa offers a powerful tool to extend mental health support beyond the clinic, enabling continuous patient engagement and streamlined care coordination. The platform's clinically validated AI can assist with automated screenings, progress monitoring, and crisis detection, freeing up clinicians to focus on complex cases. Its integration capabilities with EHRs and support for models like CoCM, CCM, and RPM can reduce administrative load and potentially generate new revenue streams. Wysa's ability to provide 24/7 AI-driven self-help ensures patients receive immediate support, improving outcomes for conditions like anxiety, depression, and chronic pain. The AI can also summarize therapeutic sessions, allowing physicians to remain more present with patients.
Wysa is designed for seamless integration into existing healthcare workflows, including Electronic Health Records (EHRs), to facilitate the flow of symptom data, risk alerts, and medication adherence insights directly into clinicians' dashboards. They also support integrations for Chronic Care Management (CCM), Collaborative Care Model (CoCM), and Remote Patient Monitoring (RPM) services, aiming to reduce technical and administrative burdens.
What the Web Says
Wysa is an AI-powered mental wellness app offering CBT, mindfulness, and guided journaling to help users manage stress and anxiety. It provides both a free version and premium features, including access to human coaches. The app is generally well-received for its accessibility and helpful exercises, though some users note limitations in the AI's conversational abilities.
Overall: PositiveStrengths
- Available 24/7 for immediate support during anxious moments.
- Provides structured exercises and coping strategies based on CBT and mindfulness.
- Offers a safe, non-judgmental, and private space for users to express themselves.
- More affordable than traditional therapy options.
- Human coaching option available for more personalized support.
- User-friendly interface and easy to navigate.
Limitations
- AI chatbot can be repetitive and its responses may feel generic or scripted.
- Chatbot may not always understand complex emotional nuances or respond correctly in conversations.
- Limited free version, with many features behind a paywall.
- Not a replacement for human therapy, especially for severe conditions or crises.
- Some users find the chatbot's requests for more information tiring or cloying.
- Pricing structure can be confusing with various subscription and coaching add-ons.
Based on reviews from: Reddit, Choosing Therapy, Healthline, AI Insights, Apple App Store, Google Play Store, Medium, YouTube
Last updated: 2026-06-19
Videos
News, demos, and interviews about Wysa.
Videos load interactively. If none appear, search YouTube for Wysa →
Press & Coverage
Frequently Asked Questions
Investors
Who's funded Wysa.
Comparisons
Related Companies
QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]
Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]